Data-independent Acquisition (DIA) Approach on Q-TOF Mass Spectrometry for In-depth Peptide Mapping of Monoclonal Antibodies
Postery | 2020 | ShimadzuInstrumentace
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
ZaměřeníProteomika
VýrobceShimadzu
Klíčová slovapeptide, dial, bevacizumab, novo, sequencing, dia, mabs, drugbank, antibodies, proposed, mapping, monoclonal, numbers, independent, alpapiek, approach, downloaded, biosimilar, peak, fragmented, data, acquisition, precisely, plays, map, assurance, sequences, mab, characterize, isolation, role, theoretical, amino, depth, fragment, accurately, widely, tof, sequence, precursor, critical, extracted, applied, spectra, ions, compared, reference, parameters, extraction, acid
Podobná PDF
In-depth Peptide Mapping of Monoclonal Antibody (mAb) by A de novo Peptide Sequencing Method on Q-TOF Mass Spectrometer with Data-independent Acquisition
2019|Shimadzu|Aplikace
Application News No. AD-0217 Biopharma / LCMS-9030 (Q-TOF) In-depth Peptide Mapping of Monoclonal Antibody (mAb) by A de novo Peptide Sequencing Method on Q-TOF Mass Spectrometer with Data-independent Acquisition Yonghai Lu and Zhaoqi Zhan Application Development & Support Centre, Shimadzu…
Klíčová slova
peptide, peptidedia, diamab, mabnovo, novomapping, mappingbevacizumab, bevacizumabchain, chainsequencing, sequencingalpapiek, alpapiekpeptides, peptidestryptic, trypticnews, newsdial, dialmonoclonal, monoclonalheavy
Disulfide Bond Characterization of Monoclonal Antibody (mAb) Using Q-TOF Mass Spectrometer
2019|Shimadzu|Aplikace
Application News Biopharma / LCMS-9030 (Q-TOF) Disulfide Bond Characterization of Monoclonal Antibody (mAb) Using Q-TOF Mass Spectrometer No. AD-0214 Yonghai Lu and Zhaoqi Zhan Application Development & Support Centre, Shimadzu (Asia Pacific), Singapore ❑ Introduction Monoclonal antibody (mAb) is emerging…
Klíčová slova
disulfide, disulfidebond, bondnovo, novobiosimilar, biosimilarchain, chainpeptide, peptidemab, mabsequencing, sequencingreduced, reducednews, newslinkages, linkagesbevacizumab, bevacizumablcms, lcmsadduct, adductbonds
LC/MS/MS Peptide Mapping Comparison of Innovator and Biosimilars of Rituximab
2019|Agilent Technologies|Aplikace
Application Note Biotherapeutics and Biosimilars LC/MS/MS Peptide Mapping Comparison of Innovator and Biosimilars of Rituximab Author Suresh Babu C.V. Agilent Technologies, Inc. Abstract The development and manufacturing of biosimilars require comparability studies with innovator biotherapeutic products. This Application Note presents…
Klíčová slova
innovator, innovatorpeptide, peptidecounts, countschain, chainmapping, mappingbiosimilar, biosimilarcharge, chargeunmodified, unmodifiedptms, ptmsheavy, heavyassaymap, assaymapttppvldsdgsfflyskl, ttppvldsdgsfflysklmabs, mabsbiosimilars, biosimilarsbravo
Structure Characterization and Differentiation of Biosimilar and Reference Products Using Unique Combination of Complementary Fragmentation Mechanisms
2014|Thermo Fisher Scientific|Postery
Structure Characterization and Differentiation of Biosimilar and Reference Products Using Unique Combination of Complementary Fragmentation Mechanisms Zhiqi Hao,1 Chen Li, 2 Shiaw-Lin Wu, 2,3 David M. Horn1 and Jonathan Josephs1 1 Thermo Fisher Scientific, San Jose, CA; 2BioAnalytix Inc, Cambridge,…
Klíčová slova
tnk, tnkglycosylation, glycosylationggnm, ggnmglycoforms, glycoformspeptide, peptideggn, ggnbiosimilar, biosimilarhcd, hcdtpa, tpaspectrum, spectrumnhnycr, nhnycrnycr, nycrsggn, sggnycr, ycretd